|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Besponsa's FDA approval for use in some leukemia patients continues to position the company as a leading player in cancer treatment.
Pfizer's last 40 years show what it takes to become a millionaire: Buy, hold, and reinvest.
When it comes to health care, pharmaceutical companies get a lot of attention, because many offer attractive yields. Pfizer’s (PFE), for example, was 3.9% late last week, and Bristol Myers Squibb’s (BMY) was 2.7%.